Subscribe

Israel Corporation Ltd (ILCO.TA)

ILA76,730.00 +1,040.00 (+1.37%)
IL TLV Basic Materials Chemicals - Specialty
Address Millennium Tower 61204
Tel Aviv, IL
CEO Yoav Doppelt
IPO 2007-12-31
ISIN IL0005760173

Explore sections of this company profile

Also trades on Other OTC · IRLCF (USD) Tel Aviv Stock Exchange · ILCO.TA (ILA)
Description

Israel Corporation Ltd operates as an international enterprise, engaged in the specialty minerals and refining sectors through its portfolio companies. Its extensive geographic presence spans Asia, Europe, North America, and South America. The company provides a comprehensive array of mineral products, encompassing bromine and bromine compounds, various salts, magnesium chloride, magnesia-based items, phosphorus-based flame retardants, and functional fluids. Additionally, it supplies potash and electricity, as well as specialized phosphate derivatives. Its agricultural division offers a diverse range of fertilizers, including controlled-release, water-soluble, and liquid formulations, alongside a variety of specialty agricultural inputs such as micronutrients (for soil and foliar application), secondary nutrients, biostimulants, soil conditioners, seed treatments, and adjuvants, notably featuring products from its FertilizerspluS line. In its refining operations, Israel Corporation Ltd manufactures fuel products, raw materials crucial for the petrochemical sector, and components for the plastics industry. Furthermore, it delivers power and water utilities to industrial clients located in Haifa. The company's operational headquarters are situated in Tel Aviv, Israel.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
ILA76,730.00 +1,040.00 (+1.37%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
11.3K
Beta
0.16
Float Shares
4.01M
Free Float %
52.6%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.48% -0.79% +10.66% +15.16% +0.91% +1.12% -16.34% -4.87% -6.25% +55.60% +951.11%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
76,730.00
DCF (Unlevered) 93,448.50 +21.8%
DCF (Levered) 1,322,814.08 +1,624.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.33
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Chemicals - Specialty: +4.7%
    +13.2% Q1'26: +14.2% (vs Q1'25)
  • EPS growth Chemicals - Specialty: +13.2%
    -50.4% Q1'26: +79.4% (vs Q1'25)
  • FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +1.7% Q1'26: +2.0% (vs Q1'25)
  • EBIT margin Chemicals - Specialty: +8.8%
    +7.5% Q1'26: +11.4% (vs Q1'25)
  • ROIC Chemicals - Specialty: +5.6%
    +4.1% Q1'26: +7.2% (vs Q1'25)
  • Share dilution Chemicals - Specialty: +0.1%
    -0.1% Q1'26: +0.1% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    2.75× Q1'26: 2.48× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.13) × ERP
WACC = 42% × Ke + 58% × Kd (5.9%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 93,448.50 Current price: 76,730.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2011
actual
Dec 2012
actual
Revenue
11.61B
est: 17.24B (-32.7%)
11.46B
est: 18.11B (-36.7%)
EBITDA
2.22B
est: 4.34B (-48.9%)
1.90B
est: 4.56B (-58.4%)
EBIT
1.67B
est: 2.83B (-41.0%)
1.34B
est: 2.97B (-55.0%)
Net Income
151.00M
-146.00M
SGA
929.00M
est: 2.38B (-61.0%)
844.00M
est: 2.50B (-66.3%)
EPS
20.05
-19.15
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-28 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-27 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-26 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-25 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-20 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-19 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-18 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-15 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-14 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-13 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-12 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-11 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-08 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-07 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-06 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-05 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-04 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-05-01 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-04-30 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-04-29 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-04-28 B+ 3/5 5/5 3/5 4/5 1/5 2/5 4/5
2026-04-27 A- 4/5 5/5 3/5 5/5 1/5 2/5 4/5
2026-04-24 A- 4/5 5/5 3/5 5/5 1/5 2/5 4/5
2026-04-23 A- 4/5 5/5 3/5 5/5 1/5 2/5 4/5
2026-04-20 A- 4/5 5/5 3/5 5/5 1/5 2/5 4/5
2026-04-17 A- 4/5 5/5 3/5 5/5 1/5 2/5 4/5
2026-04-16 A- 4/5 5/5 3/5 5/5 1/5 2/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
429.52M
OE per share TTM
57.24
Owner's Yield
6.16%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
85.9%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 64 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 VanEck Israel ETF ISRA 0.39% 591.7K 0.59%
2 iShares MSCI Israel ETF EIS 0.23% 2.02M 0.59%
3 iShares MSCI Agriculture Producers ETF VEGI 0.18% 277.3K 0.39%
4 ALPS Funds CoreCommodity Natural Resources ETF CCNR 0.15% 556.1K 0.39%
5 Avantis International Small Cap Value ETF AVDV 0.08% 14.29M 0.36%
6 Schwab Fundamental International Small Company Index ETF FNDC 0.07% 2.03M 0.39%
7 Vanguard Global Value Equity Active ETF VVLU.AX 0.06% 509.8K 0.28%
8 Avantis Global Small Cap Value UCITS ETF AVGS.L 0.03% 337.7K 0.39%
9 iShares $ Treasury Bond 3-7yr UCITS ETF CBUG.DE 0.03% 115.1K 0.10%
10 iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ 0.03% 58.2K 0.83%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
44.2K
Shares Outstanding
7.63M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Elad Aharonson President & CEO of ICL Group Ltd 10M male
Yoav Doppelt President & CEO 7M male
Uri Perelman EVP & Chief Corporate BD Officer 4M male
Aviram Lahav Chief Financial Officer of ACL 3M male
Sagi Kabla Chief Financial Officer 3M male
Maya Alschich-Kaplan VP, Deputy CEO, General Counsel & Company Secretary 3M female
Philip Brown President of the Specialty Phosphate Solutions Division of ACL male
Shay Ohayon Controller male
Idan Hizki Vice President of Business Development & Investors Relations
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits